UCB is seeking approval for treatment in moderate-to-severe plaque psoriasis
News
NHS COVID-19 app launches in England and Wales
App will automatically alert users when they come into close contact with someone with the virus
Vertex, CRISPR Therapeutics’ sickle cell gene therapy wins PRIME designation
European Medicines Agency grants designation based on phase I/II data
Digital tech has health benefits for dementia patients, project finds
The Leeds Dementia Pathfinder project supported patients and carers with tech devices
Owlstone Medical’s breath biopsy test improves detection of liver disease
Study detected Nonalcoholic Fatty Liver Disease and Nonalcoholic steatohepatitis
Sanofi, GSK ink deal with EU for 300 million COVID-19 vaccine doses
Upfront funding will be used to scale-up manufacturing
Bristol Myers Squibb’s Opdivo shows benefit in oesophageal cancers
Data presented at 2020 ESMO virtual congress
GSK’s Zejula and AZ’s Lynparza leap toward broader EU approval
Both PARP inhibitors receive positive opinions from CHMP
Roche acquires Irish biotech firm Inflazome
Swiss pharma company to acquire biotech for $449m (€380m)
UK’s chief medical officers upgrade coronavirus alert level
Decision made following review of rising COVID-19 cases
Keytruda/Lenvima combo shows promise in hard-to-treat cancers
Data shows a range of responses in different tumours
Lynparza scores long-term benefit data in BRCA-mutated ovarian cancer
Detailed results presented at ESMO also show benefit in prostate cancer
University of Edinburgh spinout Cellinta will develop gene therapies for cancer
Investors include SV Health Investors and Cancer Research UK
CHMP backs seven new meds in September meeting
Positive opinions include Pacira’s Exparel and two new vaccines from Sanofi
BMS’ Opdivo wins new NICE lung cancer backing
The drug has been approved for routine NHS commissioning for squamous or non-squamous NSCLC
